Search

everythinglearnresearchcommunity

for

Search:↓

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Using old drugs for new uses can help treat rare immune deficiencies.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Finasteride and dutasteride may increase the risk of suicide and sexual dysfunction.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Serenoa repens extract shows promise as a natural treatment for prostate cancer.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Medicare Part D causes significant coverage and cost issues for end-stage renal disease patients.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Finasteride and dutasteride increase sexual dysfunction reports.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.